Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.00 (0.00%)
Bid:
2.60
Ask:
2.80
Spread: 0.20 (7.692%)
Market Cap: £19.52m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Trading Statement

17 Jan 2008 07:01

Amphion Innovations PLC17 January 2008 Amphion Innovations plc Trading Update 17 January 2008 - Amphion Innovations plc (LSE: AMP) ('Amphion' or the'Company'), is pleased to announce that results for the 12 month period to 31December 2007 are expected to show an increase in Net Asset Value per Share of29% to $0.44 (£0.22), broadly in line with market expectations. Profit beforeTax is expected to be approximately $10.5 million, a 50% increase from theprevious year, primarily reflecting the uplift in the value of the investments. Amphion builds shareholder value in high growth companies in the medical andtechnology sectors, by using a focused, hands-on company building approach,based on decades of experience in both the US and UK. Currently there are 10Partner Companies developing proven technologies targeting substantialcommercial marketplaces, in excess of $1 billion. Each Partner Company aims toachieve a target exit value in excess of $100 million supported by Amphionmanagement team's strong track record of delivering liquidity events. During 2007, Amphion successfully helped its Partner Companies raise over $21million. Looking ahead, the Company expects to build on the substantial progress made in2007. Following a successful fundraising, WellGen is in a strong position tomeet its commercial objectives in 2008, having raised $9.5 million in October2007. Durham Scientific Crystals is also well placed following the signing of acontract with the UK Home Office in December 2007. The contract is to developits groundbreaking technology for digital x-ray imaging for use in both medicalapplications and airport security scanners to detect explosives and flammablematerial. Amphion is pleased to report that its Gulf based joint venture, MSA, has beenfully incorporated and capitalized. This will enable it to move forward with thecompany's business plan and to develop strategic partnerships for Amphion andits Partner Companies in the Gulf region. During 2007 Amphion continued to develop its two new Partner Companies, EnergyTrading International ('ETI') and DataTern Inc. ETI seeks to exploit the trendtowards automation of markets through the development of a proprietary(patented) platform for the automatic negotiation and execution of bilateral,structured trades. DataTern Inc. is being formed to develop and extract valuefrom the substantial and growing patented portfolio in Amphion's PartnerCompanies. The Company estimates that its Partner Companies have over 150individual pieces of intellectual property, double the amount at the time oflisting in August 2005. Amphion expects to announce its preliminary results for the 12 months to 31December 2007, in March 2008. Richard C.E. Morgan, Amphion's Chief Executive Officer, said: "During 2007,Amphion and our Partner Companies achieved several key milestones. We arefocused on creating shareholder value, and given the strength of our PartnerCompanies, we are very confident of being able to continue to deliver furthergrowth." For further information please contact: Amphion InnovationsCharlie Morgan:+1 (212) 210-6224 Cardew GroupTim Robertson/ Jamie Milton/Matthew Law:+44 020 7930 0777 Charles Stanley Securities, Nominated AdvisorMark Taylor/ Freddy Crossley:+44 020 7149 6000 On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20082:58 pmRNSTotal Voting Rights
8th Apr 20087:00 amRNSPartner Company Fundraising
7th Apr 20083:46 pmRNSFundraising
26th Mar 200812:36 pmRNSDirector/PDMR Shareholding
13th Mar 20087:12 amRNSFinal Results
3rd Mar 20087:01 amRNSPrivateMarkets Fundraising
27th Feb 20088:00 amRNSNotice of Preliminary Results
31st Jan 20084:51 pmRNSTotal Voting Rights
17th Jan 20087:01 amRNSTrading Statement
7th Jan 20087:00 amRNSDirectors Dealings
30th Nov 20074:53 pmRNSTotal Voting Rights
12th Nov 20077:01 amRNSIssue of Equity
5th Nov 20071:59 pmRNSResult of EGM
5th Nov 20071:39 pmRNSResult of EGM
31st Oct 20075:49 pmRNSTotal Voting Rights-Amendment
31st Oct 20072:18 pmRNSTotal Voting Rights
29th Oct 20077:00 amRNSWellGen Series C Financing
12th Oct 20077:30 amRNSIssue of Equity
12th Sep 20077:01 amRNSInterim Results
28th Aug 200710:25 amRNSNotice of Results
22nd Aug 20077:01 amRNSChange of Adviser
16th Aug 20079:31 amRNSRe: AIM Rule 26
14th Aug 20077:00 amRNSFundraising
30th Jul 20077:01 amRNSRe: Series C Financing
12th Jul 20079:19 amRNSPatent Awarded
2nd Jul 20077:01 amRNSPlacing
7th Jun 20077:01 amRNSAGM Statement
21st May 20071:52 pmRNSRe: Symposium
21st May 20071:00 pmBUSApplied Genomics Paves the Way for Improved Prevention, Diagnosis, and Treatment of Disease
14th May 20074:25 pmBUSAmphion Innovations plc (LSE: ''AMP'') Announces First Annual Science & Business Symposium ''Building Market Value from the World of Genetics''
30th Apr 200711:02 amRNSDirector Shareholdings
11th Apr 200711:31 amRNSResearch Update
5th Apr 20071:00 pmBUSAmphion Innovations Partner Company Motif Biosciences Closes $1m Financing
5th Apr 20079:24 amRNSDirector/PDMR Shareholding
5th Apr 20077:01 amRNSRe: Series C Financing
23rd Mar 20072:42 pmBUSPort of Barbados Selects AXCESS to Provide Security Systems for the Cricket World Cup 2007
23rd Mar 20077:01 amRNSRe: Cricket World Cup
15th Mar 20077:01 amRNSFinal Results
26th Feb 20074:44 pmRNSNotice of Results
9th Feb 20077:00 amRNSRe: Financing
16th Jan 20073:25 pmBUSAmphion Innovations, plc Announces Creation of a Gulf-based Joint Venture
16th Jan 20073:19 pmBUSAmphion Innovations, plc Offers Trading Update
16th Jan 20077:01 amRNSJoint Venture
16th Jan 20077:00 amRNSTrading Update
8th Jan 20074:28 pmBUSAmphion Innovations plc Announces Fundraising
8th Jan 20071:08 pmRNSFundraising - Replacement
8th Jan 20077:00 amRNSFundraising
27th Nov 20063:04 pmBUSAmphion Innovations plc Acquires 35% Stake in Manchester Molecular Diagnostic Spin-out Company
27th Nov 20067:00 amRNSAcquires Stake in Company
13th Nov 20062:58 pmBUSAmphion Innovations plc Partner Company Supertron Acquires Spin Systems

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.